Operation Warp Speed, the U.S. government's crash program to inoculate 300 million Americans against the coronavirus, includes a number of pharmaceutical partners like Emergent BioSolutions in Baltimore. CBS News correspondent David Martin toured one of Emergent's manufacturing suites where the company is producing two COVID-19 vaccines awaiting FDA approval.
